title: Highlighting complications over successes in occurrence of sectoral choroidal occlusive vasculopathy.
authors.forename: David H
authors.initials: DH
authors.lastname: Abramson
authors.forename: Y Pierre
authors.initials: YP
authors.lastname: Gobin
authors.forename: Ira
authors.initials: I
authors.lastname: Dunkel
authors.forename: Brian P
authors.initials: BP
authors.lastname: Marr
authors.forename: Scott
authors.initials: S
authors.lastname: Brodie
authors.forename: K Bailey
authors.initials: KB
authors.lastname: Freund
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D015862:Choroid Diseases / Q000139:chemically induced*; D006801:Humans; D008558:Melphalan / Q000009:adverse effects*; D009880:Ophthalmic Artery; D015356:Retinal Artery Occlusion / Q000139:chemically induced*; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan